| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 18, 2025 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 91.3 | +51,451 | 91.08% | ✗ | $16.1K |
| Nov 7, 2024 | Nov 12, 2024 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 47.5 | -1,102 | -1.91% | ✗ | $6.7K |
| Sep 16, 2024 | Sep 17, 2024 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 47.5 | -661 | -1.21% | ✗ | $4.2K |
| Feb 13, 2024 | Feb 15, 2024 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 91.3 | +25,565 | 95.80% | ✗ | $11.3K |
| Aug 30, 2023 | Aug 31, 2023 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 47.5 | -661 | -2.42% | ✗ | $1.9K |
| Jan 30, 2023 | Feb 1, 2023 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 46.3 | -1,301 | -20.33% | ✗ | $10.1K |
| May 26, 2022 | Jun 14, 2022 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 47.5 | -1,102 | -29.39% | ✗ | $7.7K |
| Sep 10, 2021 | Sep 14, 2021 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 7.5 | -12,500 | -100.00% | ✓ | $625K |
| Jul 29, 2021 | Aug 2, 2021 | C4 Therapeutics, Inc. | Chief Legal Officer | Sell | 7.5 | -12,500 | -100.00% | ✓ | $562.5K |